翰思艾泰生物医药科技（武汉）股份有限公司（股票名称：翰思艾泰-B，股票代码：03378）于2026年7月8日回购H股普通股3.38万股，占回购前公司已发行股份（不包括库藏股）总数的约0.025%。每股回购价介乎28.42港元至30.00港元，合共支付约98.01万港元。
回购完成后，公司已发行股份（不包括库藏股）数目变更为134,374,230股，库藏股数目为1,844,600股，合计已发行股份总数维持在136,218,830股。公司此前于2026年6月24日通过回购授权，当前可回购股份余量为13,469,683股。
公司确认已遵守香港联合交易所有限公司证券上市规则及相关法律法规。公告由董事长兼执行董事张发明签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.